203 related articles for article (PubMed ID: 37305393)
1. Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis.
Li T; Fu X; Wang J; Shang W; Wang X; Zhang L; Li J
Oncol Res; 2023; 31(3):345-359. PubMed ID: 37305393
[TBL] [Abstract][Full Text] [Related]
2. The role of KDM4A-mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis.
Li XX; Xu JK; Su WJ; Wu HL; Zhao K; Zhang CM; Chen XK; Yang LX
Kaohsiung J Med Sci; 2024 Feb; 40(2):161-174. PubMed ID: 37873881
[TBL] [Abstract][Full Text] [Related]
3. microRNA-155-3p attenuates intervertebral disc degeneration via inhibition of KDM3A and HIF1α.
Zhou X; Li J; Teng J; Liu Y; Zhang D; Liu L; Zhang W
Inflamm Res; 2021 Mar; 70(3):297-308. PubMed ID: 33486545
[TBL] [Abstract][Full Text] [Related]
4. FOXO3a protects glioma cells against temozolomide-induced DNA double strand breaks via promotion of BNIP3-mediated mitophagy.
He C; Lu S; Wang XZ; Wang CC; Wang L; Liang SP; Luo TF; Wang ZC; Piao MH; Chi GF; Ge PF
Acta Pharmacol Sin; 2021 Aug; 42(8):1324-1337. PubMed ID: 33879840
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9.
Li ZF; Meng DD; Liu YY; Bi FG; Tian K; Xu JZ; Sun JG; Gu CX; Li Y
Chem Biol Interact; 2022 Jan; 351():109759. PubMed ID: 34826399
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z
Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
[TBL] [Abstract][Full Text] [Related]
7. Lysine-specific demethylase 3A is important for autophagic occurrence.
Kim J; Choi SA; Kim J; Kim H; Baek SH
Biochem Biophys Res Commun; 2020 May; 526(1):176-183. PubMed ID: 32201075
[TBL] [Abstract][Full Text] [Related]
8. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway.
Bu X; Qu X; Guo K; Meng X; Yang X; Huang Q; Dou W; Feng L; Wei X; Gao J; Sun W; Chao M; Han L; Hu Y; Shen L; Zhang J; Wang L
Int J Biol Sci; 2021; 17(12):3013-3023. PubMed ID: 34421346
[No Abstract] [Full Text] [Related]
9. Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cells.
Harder BG; Peng S; Sereduk CP; Sodoma AM; Kitange GJ; Loftus JC; Sarkaria JN; Tran NL
Mol Med; 2019 Nov; 25(1):49. PubMed ID: 31726966
[TBL] [Abstract][Full Text] [Related]
10. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
Xu JX; Yang Y; Zhang X; Luan XP
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
[TBL] [Abstract][Full Text] [Related]
12. Caffeine Inhibits Growth of Temozolomide-Treated Glioma via Increasing Autophagy and Apoptosis but Not via Modulating Hypoxia, Angiogenesis, or Endoplasmic Reticulum Stress in Rats.
Chen JC; Hwang JH
Nutr Cancer; 2022; 74(3):1090-1096. PubMed ID: 34060393
[TBL] [Abstract][Full Text] [Related]
13. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP
J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988
[TBL] [Abstract][Full Text] [Related]
14. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway.
Hu YH; Jiao BH; Wang CY; Wu JL
CNS Neurosci Ther; 2021 May; 27(5):552-563. PubMed ID: 33460245
[TBL] [Abstract][Full Text] [Related]
15. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
17. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling.
Song Y; Li L; Xi Y
Tissue Cell; 2023 Dec; 85():102253. PubMed ID: 37890327
[TBL] [Abstract][Full Text] [Related]
18. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
[No Abstract] [Full Text] [Related]
19. Roscovitine effectively enhances antitumor activity of temozolomide in vitro and in vivo mediated by increased autophagy and Caspase-3 dependent apoptosis.
Pandey V; Ranjan N; Narne P; Babu PP
Sci Rep; 2019 Mar; 9(1):5012. PubMed ID: 30899038
[TBL] [Abstract][Full Text] [Related]
20. Exosomes Derived from Hypoxic Glioma Cells Reduce the Sensitivity of Glioma Cells to Temozolomide Through Carrying miR-106a-5p.
Wu P; Guo J; Yang H; Yuan D; Wang C; Wang Z
Drug Des Devel Ther; 2022; 16():3589-3598. PubMed ID: 36248244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
